These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 5962711

  • 21. Retreatment of drug resistant tuberculosis at Battey State Hospital.
    Corpe RF, Blalock FA.
    Dis Chest; 1965 Sep; 48(3):305-10. PubMed ID: 5830645
    [No Abstract] [Full Text] [Related]

  • 22. [Observations on antituberculous drug resistance among pulmonary tuberculosis patients at the national sanatoria in Kyushu district. 4. The primary and the secondary antituberculous agents].
    Yamaguchi S.
    Iryo; 1968 Oct; 22(10):1120-4. PubMed ID: 5710123
    [No Abstract] [Full Text] [Related]

  • 23. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN, Barrera L.
    Medicina (B Aires); 2007 Oct; 67(3):231-7. PubMed ID: 17628909
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Ethionamide and cycloserine in the treatment of middle-aged and aged patients with pulmonary tuberculosis].
    Vasil'eva IR, Zhmudskaia EV, Trifonova VK, Chesmochakova IV.
    Probl Tuberk; 1970 Jun; 48(9):21-4. PubMed ID: 5518269
    [No Abstract] [Full Text] [Related]

  • 31. Treatment of pulmonary tuberculosis with ethionamide, cycloserine and pyrazinamide in Hong Kong.
    Horsfall PA.
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():91-100. PubMed ID: 4662516
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Limitations of the clinical activity of cycloserine therapy. Appearance of resistance to cycloserine when used alone and in combination with other drugs.
    Molina C.
    Scand J Respir Dis Suppl; 1970 Aug; 71():296-305. PubMed ID: 5272000
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Current questions in the treatment of patients with chronic destructive pulmonary tuberculosis].
    Mamolat AS, Bialik IB, Khutorskaia VD.
    Klin Med (Mosk); 1976 Dec; 54(12):72-8. PubMed ID: 189127
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.